Diagnosis and Treatment of Lupus Nephritis: Survey Results on Four Important Issues.
10.4078/jrd.2013.20.3.156
- Author:
Young Bin JOO
1
;
Yoon Kyoung SUNG
;
Yong Beom PARK
;
Chang Hee SUH
;
Seung Cheol SHIM
;
Young Ho LEE
;
Jisoo LEE
;
Hye Soon LEE
;
Hoon Suk CHA
;
Sang Cheol BAE
Author Information
1. Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea. scbae@hanyang.ac.kr
- Publication Type:Original Article
- Keywords:
Lupus nephritis;
Treatment;
Guideline
- MeSH:
Biopsy;
Cyclophosphamide;
Surveys and Questionnaires;
Humans;
Lupus Nephritis;
Mycophenolic Acid;
Proteinuria;
Tacrolimus
- From:Journal of Rheumatic Diseases
2013;20(3):156-165
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVES: To investigate the perception of and treatment pattern with regard to the four important issues in the management of lupus nephritis (LN), and to identify which parts of the LN treatment are difficult for physicians to carry out in clinical practice. METHODS: Four steps were carried out: pre-survey, LN symposium, post-survey, and meeting after the symposium.The two surveys were conducted with the same contents regarding renal biopsy, induction and maintenance treatment for class III and IV LN, and treatment for class V LN. The results of the first survey and the changes in opinion reflected in the second survey were comparatively analyzed. RESULTS: In the first survey, most of the respondent physicians replied that they would immediately conduct biopsy in the case of significant proteinuria. For the induction treatment of class III and IV LN, most of the respondent physicians selected high-dose cyclophosphamide. Mycophenolate mofetil and steroid combination therapy were selected for the maintenance treatment, and tacrolimus for the treatment of class V LN. There was a controversy in the drug selection, however, especially on the maintenance treatment of class III and IV LN and on the treatment of non-responsive class V LN. CONCLUSION: Some discrepancies were found in the treatment of LN in the real world. Although no recommendation was made for Korean LN patients in this study, the study results will help physicians select the most reasonable treatment for Korean LN patients based on experts' experiences and objective evidence.
